Forte Biosciences's total assets for Q1 2024 were $32.02M, a decrease of -17.86% from the previous quarter. FBRX total liabilities were $3.33M for the fiscal quarter, a -9.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.